Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 36.9 SEK -6.11% Market Closed
Market Cap: 1.3B SEK
Have any thoughts about
Bactiguard Holding AB?
Write Note

Net Margin
Bactiguard Holding AB

-22%
Current
-31%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-22%
=
Net Income
-56.1m
/
Revenue
255m

Net Margin Across Competitors

Country SE
Market Cap 1.3B SEK
Net Margin
-22%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Net Margin
12%
Country DK
Market Cap 178.7B DKK
Net Margin
19%
Country US
Market Cap 16.1B USD
Net Margin
11%
Country KR
Market Cap 10.3T KRW
Net Margin
-358%
Country CN
Market Cap 49B CNY
Net Margin
42%
Country US
Market Cap 6.5B USD
Net Margin
29%
Country CA
Market Cap 6.4B USD
Net Margin
-8%
Country UK
Market Cap 4.7B GBP
Net Margin
7%
Country US
Market Cap 5.7B USD
Net Margin
9%
No Stocks Found

Bactiguard Holding AB
Glance View

Market Cap
1.3B SEK
Industry
Health Care

Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.

BACTI B Intrinsic Value
29.24 SEK
Overvaluation 21%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-22%
=
Net Income
-56.1m
/
Revenue
255m
What is the Net Margin of Bactiguard Holding AB?

Based on Bactiguard Holding AB's most recent financial statements, the company has Net Margin of -22%.